These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15019281)

  • 1. Molecular basis of antigen recognition by insulin specific T cell receptor.
    Sugiyama S; Kohyama M; Oda M; Azuma T; Wither JE; Hozumi N
    Immunol Lett; 2004 Feb; 91(2-3):133-9. PubMed ID: 15019281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues in the T cell receptor CDR3 determine the antigenic reactivity patterns of insulin-reactive hybridomas.
    Wither J; Pawling J; Phillips L; Delovitch T; Hozumi N
    J Immunol; 1991 May; 146(10):3513-22. PubMed ID: 2026880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.
    Glimcher LH; Schroer JA; Chan C; Shevach EM
    J Immunol; 1983 Dec; 131(6):2868-74. PubMed ID: 6196405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
    Hsu BL; Donermeyer DL; Allen PM
    J Immunol; 1996 Sep; 157(6):2291-8. PubMed ID: 8805626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of Ia:nominal antigen complementary determinants recognized by T cells in studies of gene complementation in response to insulin.
    Lin CC; Hansen TH; Passmore HC; Rosenthal AS; Tse HY; Walsh WD; Kanamori S
    J Immunol; 1984 Jan; 132(1):303-9. PubMed ID: 6197448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictable acquisition of a new MHC recognition specificity following expression of a transfected T-cell receptor beta-chain gene.
    Saito T; Germain RN
    Nature; 1987 Sep 17-23; 329(6136):256-9. PubMed ID: 2442621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice.
    Spinella DG; Hansen TH; Walsh WD; Behlke MA; Tillinghast JP; Chou HS; Whiteley PJ; Kapp JA; Pierce CW; Shevach EM
    J Immunol; 1987 Jun; 138(11):3991-5. PubMed ID: 2953795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of the TCR-MHC-peptide complex.
    Michielin O; Luescher I; Karplus M
    J Mol Biol; 2000 Jul; 300(5):1205-35. PubMed ID: 10903865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
    Schmid DA; Depta JP; Lüthi M; Pichler WJ
    Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction.
    O'Hara RM; Byrne MC; Kuchroo VK; Nagelin A; Whitters MJ; Jayaraman S; Henderson SL; Dorf ME; Collins M
    J Immunol; 1995 Mar; 154(5):2075-81. PubMed ID: 7868884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis.
    Holmdahl M; Ahlfors SR; Holmdahl R; Hansson C
    Chem Res Toxicol; 2008 Aug; 21(8):1514-23. PubMed ID: 18616296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen processing and the human T cell receptor repertoire for insulin.
    Miller GG; Hoy JF; Nell LJ; Thomas JW
    J Immunol; 1988 Nov; 141(10):3293-8. PubMed ID: 2460529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes.
    Plaksin D; Polakova K; McPhie P; Margulies DH
    J Immunol; 1997 Mar; 158(5):2218-27. PubMed ID: 9036968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of T-cell alloreactivity.
    Felix NJ; Allen PM
    Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes.
    Happ MP; Kubo RT; Palmer E; Born WK; O'Brien RL
    Nature; 1989 Dec; 342(6250):696-8. PubMed ID: 2594068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a T cell receptor Valpha11 (AV11S5) domain: new canonical forms for the first and second complementarity determining regions.
    Machius M; Cianga P; Deisenhofer J; Ward ES
    J Mol Biol; 2001 Jul; 310(4):689-98. PubMed ID: 11453680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.